MDR Bacterial Infections Our Treatment Option

More documents

Recommendations

Info

KPC-2–p K. pneumoniae in Greek HospitalsMaria Souli, Irene Galani, Anastasia Antoniadou. An Outbreak of Infection due to b-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes. Clinical InfectiousDiseases 2010; 50:364–73.
Maria Souli, Irene Galani, Anastasia Antoniadou. An Outbreak of Infection due to b-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes. Clinical InfectiousDiseases 2010; 50:364–73.
Page 1 and 2: MDR Bacterial Infections:Our Treatm
Page 5 and 6: IDSA News: 10 New Antibiotics by 20
Page 7 and 8: 60504030201001911102010719992000261
Page 9: Definition & Action of KPC, CRKP an
Page 13 and 14: Antimicrobial Susceptibility for ND
Page 15 and 16: KPC-p K. pneumoniaeisolate. (USA)Ca
Page 18 and 19: MIC distributions of NDM-1 Enteroba
Page 20 and 21: Drug of Choice for ESBL-producingEn
Page 22 and 23: Antimicrobial Option by Risk Level
Page 24 and 25: In vitro activities of fosfomycin a
Page 26 and 27: 0.5, 1.0, 2.0-gm Human Simulated Pr
Page 28 and 29: FIC Index & InterpretationInterpret
Page 30 and 31: FIC Index of MDR P. aeruginosaStrai
Page 32 and 33: Population PharmacokineticAnalysis
Page 34 and 35: Attenuation of Colistin Bactericida
Page 36 and 37: Pharmacokinetic/Pharmacodynamic Det
Page 38 and 39: Recommended Definite Therapy for Se
Page 40 and 41: Breakpoint Criteria of Vancomycin f
Page 42 and 43: One Gram bid: Enough for Vancomycin
Page 44 and 45: การใชยา vancomycin
Page 46 and 47: ยาขนานอื่น ถ
Page 48 and 49: Early Combination Rx vs. Monotherap
Page 54: Thank youAny Comment?Any Question?

MDR Bacterial Infections Our Treatment Option

Create successful ePaper yourself

Delete template?

Save as template?